BRCA1 germline mutations lead to an increased risk of breast and ovarian cancer, but the mechanisms by which the product of this gene functions as a tumor suppressor have remained elusive. Now, analysis of a missense BRCA1 variant shows that it can epigenetically regulate an miRNA implicated in cancer, providing new mechanistic insights (pages 1275–1282).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ford, D. et al. Am. J. Hum. Genet. 62, 676–689 (1998).
Narod, S.A. & Foulkes, W.D. Nat. Rev. Cancer 4, 665–676 (2004).
Atchley, D.P. et al. J. Clin. Oncol. 26, 4282–4288 (2008).
Lee, M.S. et al. Cancer Res. 70, 4880–4890 (2010).
Morris, J.R. et al. Hum. Mol. Genet. 15, 599–606 (2006).
Chang, S., Biswas, K., Martin, B.K., Stauffer, S. & Sharan, S.K. J. Clin. Invest. 119, 3160–3171 (2009).
Chang, S. et al. Nat. Med. 17, 1275–1282 (2011).
Lovelock, P.K. et al. Breast Cancer Res. 9, R82 (2007).
O'Connell, R.M. et al. J. Exp. Med. 205, 585–594 (2008).
Costinean, S. et al. Blood 114, 1374–1382 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Velkova, A., Monteiro, A. Epigenetic tumor suppression by BRCA1. Nat Med 17, 1183–1185 (2011). https://doi.org/10.1038/nm.2493
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2493
